FMC (NYSE:FMC) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.78 by 1.69 percent. This is a 5.23 percent increase over earnings of $1.72 per share from the same period last year. The company reported quarterly sales of $1.24 billion which beat the analyst consensus estimate of $1.23 billion by 0.98 percent. This is a 7.53 percent increase over sales of $1.16 billion the same period last year.
Pfizer Receives CHMP Positive Opinion For Novel COVID-19 Oral Treatment
Pfizer Inc. (NYSE:PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional marketing
